Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Stock Overview
Symbol
ANIX
Exchange
Nasdaq
Market Cap
151.09m
Last Price
$4.59
52-Week Range
$2.07 - $4.98
11/28/2025 06:00 PM EST
Investor Relations
Mike Catelani
President, COO & CFO
T: 408-708-9808